(Q63807711)
Statements
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes (English)
0 references
24 July 2017
0 references
30 September 2024
0 references
49
0 references
12 month
0 references
21 year
0 references